Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United States
- 28 February 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (2) , 85-93
- https://doi.org/10.1016/0732-8893(94)00147-o
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Genetics and mechanisms of glycopeptide resistance in enterococciAntimicrobial Agents and Chemotherapy, 1993
- Increasing problems in the therapy of enterococcal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- In Vivo Development of Teicoplanin Resistance in a VanB Enterococcus faecium IsolateThe Journal of Infectious Diseases, 1993
- In vivo antibiotic synergism: contribution of animal modelsAntimicrobial Agents and Chemotherapy, 1992
- Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institutionAntimicrobial Agents and Chemotherapy, 1991
- Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1990
- Mechanisms of resistance of enterococci to beta-lactam antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256Antimicrobial Agents and Chemotherapy, 1990
- High-Level Penicillin Resistance among Isolates of EnterococciAnnals of Internal Medicine, 1989
- Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility testsAntimicrobial Agents and Chemotherapy, 1989